| Micah A Smith, AG-ACNP | |
|
1215 Lee St, Charlottesville, VA 22908-0816 | |
| (434) 924-2283 | |
| (434) 982-0019 |
| Full Name | Micah A Smith |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner - Acute Care |
| Location | 1215 Lee St, Charlottesville, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356122675 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207LC0200X | Anesthesiology - Critical Care Medicine | 0024188319 (Virginia) | Secondary |
| 363LA2100X | Nurse Practitioner - Acute Care | 0024188319 (Virginia) | Primary |
| Entity Name | University Of Virginia Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033138250 PECOS PAC ID: 4880590728 Enrollment ID: O20040102000780 |
News Archive
Today, the U.S. Food and Drug Administration approved Gallium 68 PSMA-11 (Ga 68 PSMA-11) - the first drug for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer.
Kaiser Health News staff writer Julie Appleby writes: "Too many nonprofit hospitals fail to adequately publicize their charity-care programs, two advocacy groups say in a survey report released today"
Restricting the sale of tobacco and tobacco products for persons under the age of 21 could lead to a decline in smoking rates across the USA.
Pharmasset, Inc. announced today interim efficacy and safety results from its ongoing 28-day phase 2a study with PSI-7977 dosed once daily in combination with Pegasys® (peginterferon alfa 2a) and Copegus® (ribavirin) in patients with hepatitis C virus (HCV) genotype 1 who have not been treated previously.
It is estimated that between 14,000 and 15,000 Americans have amyotrophic lateral sclerosis (ALS), according to the National Institutes of Health. Symptoms of ALS, also known as Lou Gehrig's disease, may be subtle at first but develop into more obvious muscle weakness and paralysis.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Micah A Smith, AG-ACNP Po Box 9007, Charlottesville, VA 22906-9007 Ph: () - | Micah A Smith, AG-ACNP 1215 Lee St, Charlottesville, VA 22908-0816 Ph: (434) 924-2283 |
News Archive
Today, the U.S. Food and Drug Administration approved Gallium 68 PSMA-11 (Ga 68 PSMA-11) - the first drug for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer.
Kaiser Health News staff writer Julie Appleby writes: "Too many nonprofit hospitals fail to adequately publicize their charity-care programs, two advocacy groups say in a survey report released today"
Restricting the sale of tobacco and tobacco products for persons under the age of 21 could lead to a decline in smoking rates across the USA.
Pharmasset, Inc. announced today interim efficacy and safety results from its ongoing 28-day phase 2a study with PSI-7977 dosed once daily in combination with Pegasys® (peginterferon alfa 2a) and Copegus® (ribavirin) in patients with hepatitis C virus (HCV) genotype 1 who have not been treated previously.
It is estimated that between 14,000 and 15,000 Americans have amyotrophic lateral sclerosis (ALS), according to the National Institutes of Health. Symptoms of ALS, also known as Lou Gehrig's disease, may be subtle at first but develop into more obvious muscle weakness and paralysis.
› Verified 7 days ago